In:
Current Opinion in Ophthalmology, Ovid Technologies (Wolters Kluwer Health), Vol. 33, No. 4 ( 2022-07), p. 318-323
Kurzfassung:
The current review aims to describe recent advancements in treatment of corneal ectasias and its effect on indications for corneal transplantation. Recent findings The majority of patients affected by ectatic corneal disease use contact lenses to correct resulting astigmatism. Patients who are intolerant of contact lenses or cannot achieve acceptable vision through conservative measures could consider keratoplasty. However, continuing advancements in both nonsurgical and surgical treatments are either reducing or delaying the need for keratoplasty in patients affected by ectatic corneal disease. Summary Corneal transplantation has been the mainstay of treatment for patients with advanced ectatic corneal disease. In the past decade, numerous improvements have been occurred to make contact lenses not only more effective for visual correction, but also more comfortable. Although corneal cross-linking is the only proven treatment known to prevent progression of disease, several other therapies show early potential for those in which cross-linking is contraindicated. Patients now have access to a wider range of therapies before considering keratoplasty.
Materialart:
Online-Ressource
ISSN:
1040-8738
,
1531-7021
DOI:
10.1097/ICU.0000000000000862
Sprache:
Englisch
Verlag:
Ovid Technologies (Wolters Kluwer Health)
Publikationsdatum:
2022
ZDB Id:
2026983-3
